MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with L

Lanthanum carbonate

Lanthanum carbonate 1g chewable tablets

Incompatible

Stability notes for Lanthanum carbonate 1g chewable tablets

Chewable tablets, unsuitable.

Provenance

This compatibility recommendation is derived from Fosrenol 1g chewable tablets (Takeda UK Ltd).

Suppliers (4) of Lanthanum carbonate 1g chewable tablets
Fosrenol 1000mg chewable tablets (Takeda UK Ltd)
Lanthanum carbonate 1g chewable tablets (A A H Pharmaceuticals Ltd)
Lanthanum carbonate 1g chewable tablets (Alliance Healthcare (Distribution) Ltd)
Lanthanum carbonate 1g chewable tablets (Viatris UK Healthcare Ltd)

Lanthanum carbonate 500mg chewable tablets

Incompatible

Stability notes for Lanthanum carbonate 500mg chewable tablets

Chewable tablets, unsuitable.

Provenance

This compatibility recommendation is derived from Fosrenol 500mg chewable tablets (Takeda UK Ltd).

Suppliers (4) of Lanthanum carbonate 500mg chewable tablets
Fosrenol 500mg chewable tablets (Takeda UK Ltd)
Lanthanum carbonate 500mg chewable tablets (A A H Pharmaceuticals Ltd)
Lanthanum carbonate 500mg chewable tablets (Alliance Healthcare (Distribution) Ltd)
Lanthanum carbonate 500mg chewable tablets (Viatris UK Healthcare Ltd)

Lanthanum carbonate 750mg chewable tablets

Incompatible

Stability notes for Lanthanum carbonate 750mg chewable tablets

Chewable tablets, unsuitable.

Provenance

This compatibility recommendation is derived from Fosrenol 750mg chewable tablets (Takeda UK Ltd).

Suppliers (4) of Lanthanum carbonate 750mg chewable tablets
Fosrenol 750mg chewable tablets (Takeda UK Ltd)
Lanthanum carbonate 750mg chewable tablets (A A H Pharmaceuticals Ltd)
Lanthanum carbonate 750mg chewable tablets (Alliance Healthcare (Distribution) Ltd)
Lanthanum carbonate 750mg chewable tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.